Global Animal Health Diagnosis Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Animal Health Diagnosis market size will reach US$ 8163 million by 2031.
Diagnosis is an integral part of disease prevention and management as a minor outbreak of the disease can spread quickly and pose a threat to the entire population in the vicinity. Disease diagnosis of an animal forms the connecting link between the cause of the disease and the cure of the disease. There is a requirement for rapid methods that can provide answers related to the disease in terms of its cause and the probable solution.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 18%.
LPI (LP Information)' newest research report, the “Animal Health Diagnosis Industry Forecast” looks at past sales and reviews total world Animal Health Diagnosis sales in 2024, providing a comprehensive analysis by region and market sector of projected Animal Health Diagnosis sales for 2025 through 2031. With Animal Health Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal Health Diagnosis industry.
This Insight Report provides a comprehensive analysis of the global Animal Health Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Animal Health Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Animal Health Diagnosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal Health Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal Health Diagnosis.
This report presents a comprehensive overview, market shares, and growth opportunities of Animal Health Diagnosis market by product type, application, key players and key regions and countries.
Segmentation by Type:
Clinical Biochemistry
Urinalysis
Immunodiagnostics
Hematology
Molecular Diagnostics
Segmentation by Application:
Veterinary Hospitals
Veterinary Clinics
Research Institutes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IDEXX Laboratories (US)
Abaxis (US)
Thermo Fisher Scientific (US)
Neogen (US)
Heska (US)
Zoetis (US)
QIAGEN (Netherlands)
Biomerieux (France)
Virbac (France)
Randox Laboratories (UK)
Please note: The report will take approximately 2 business days to prepare and deliver.
Diagnosis is an integral part of disease prevention and management as a minor outbreak of the disease can spread quickly and pose a threat to the entire population in the vicinity. Disease diagnosis of an animal forms the connecting link between the cause of the disease and the cure of the disease. There is a requirement for rapid methods that can provide answers related to the disease in terms of its cause and the probable solution.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 18%.
LPI (LP Information)' newest research report, the “Animal Health Diagnosis Industry Forecast” looks at past sales and reviews total world Animal Health Diagnosis sales in 2024, providing a comprehensive analysis by region and market sector of projected Animal Health Diagnosis sales for 2025 through 2031. With Animal Health Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal Health Diagnosis industry.
This Insight Report provides a comprehensive analysis of the global Animal Health Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Animal Health Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Animal Health Diagnosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal Health Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal Health Diagnosis.
This report presents a comprehensive overview, market shares, and growth opportunities of Animal Health Diagnosis market by product type, application, key players and key regions and countries.
Segmentation by Type:
Clinical Biochemistry
Urinalysis
Immunodiagnostics
Hematology
Molecular Diagnostics
Segmentation by Application:
Veterinary Hospitals
Veterinary Clinics
Research Institutes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IDEXX Laboratories (US)
Abaxis (US)
Thermo Fisher Scientific (US)
Neogen (US)
Heska (US)
Zoetis (US)
QIAGEN (Netherlands)
Biomerieux (France)
Virbac (France)
Randox Laboratories (UK)
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
87 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
